Prostatic Hyperplasia (DBCOND0005936)

Identifiers

Synonyms
Hyperplasia Prostatic / Prostatic hyperplasia / Benign prostatic hyperplasia / Hyperplasia of prostate (disorder) / Hyperplasia of the prostate / Hyperplasia of prostate / Benign prostatic hypertrophy / Prostatic hypertrophy (benign) / BPH / Enlarged prostate (benign) / Benign prostatic hyperplasia (disorder)

Associated Data

Indicated Drugs and Targets
Not Available
Clinical Trials
IdentifierTitleDrug(s)PurposePhaseStatus
NCT03099421
Prostatic Artery Embolization for Benign Prostatic ObstructionNo drug interventionstreatmentNot Availablecompleted
NCT01338623
Bioequivalence Study of Tansulosine 0,4 mg Capsule in Health Subjects -Fed StateNo drug interventionsNot Available4unknown_status
NCT06161506
Surface Electrical Stimulation for Urinary Incontinence in Men Treated for Prostate CancerNo drug interventionstreatment2recruiting
NCT03354416
Profiling of Radiological Factors in Treatment and Outcomes in Prostate CancerNo drug interventionsNot AvailableNot Availablerecruiting
NCT01330303
SECOTEX® (Tamsulosin Hydrochloride) Bioequivalence Study Brazil - Fed AdminNo drug interventionsother1completed
NCT00062790
Effect Of Dutasteride On Intraprostatic Dihydrotestosterone (DHT) Levelstreatment4completed
NCT00399464
Efficacy and Safety of SL77.0499-10 (Alfuzosin) Versus Placebo and Tamsulosin in Japanese Patients With Benign Prostatic Hyperplasiatreatment3completed
NCT02241902
Impact of Postoperative Pyuria on Treatment Outcomes After PVPNo drug interventionsNot AvailableNot Availableunknown_status
NCT01376284
Drug Use Investigation for AVOLVE(BPH)Not AvailableNot Availablecompleted
NCT02278679
Digital Rectal Exam Proficiency ToolNo drug interventionsNot AvailableNot Availableunknown_status
NCT01332487
Evaluating the Impact of Early Versus Delayed 5 Alpha Reductase Inhibitor Treatment on the Risk of Emergent Surgery in Men With Benign Prostatic HyperplasiaNo drug interventionsNot AvailableNot Availablecompleted
NCT02244333
Efficacy, Tolerability and Safety of ALNA® in Patients With Benign Prostatic Syndrome (BPS)No drug interventionsNot AvailableNot Availablecompleted
NCT06257654
One-year Results After Single-center Water Vapor Thermal Therapy for Symptomatic Benign Prostatic Hyperplasia.No drug interventionsNot AvailableNot Availablecompleted
NCT00537654
A Study To Compare Giving AVODART And FLOMAX Together Or In A Combination Capsule In The Fed And Fasted StateNo drug interventionstreatment1completed
NCT00563654
Randomized Trial Comparing Alfuzosin GITS 10 mg Daily With Placebo for Trial Without Catheter in Acute Urinary Retention With Long Term Follow uptreatmentNot Availableterminated
NCT01657851
Bioequivalence - Duodart Against Avodart & Omnictreatment1completed
NCT01323998
Benign Prostatic Hypertrophy Treatment Patterns & Outcomes: MarketscanNo drug interventionsNot AvailableNot Availablecompleted
NCT00527605
Dutasteride 0.5mg For The Treatment Of Chinese Patients With Benign Prostatic Hyperplasia (BPH)treatment3completed
NCT01386983
Clinical and Economic Outcomes of Patients Utilizing Combination Therapy for Enlarged Prostates: A Henry Ford Database AssessmentNot AvailableNot Availablecompleted
NCT04760483
Office Based Transperineal Laser Ablation for Benign Prostatic Hyperplasia HYPERPLASIANo drug interventionstreatment1active_not_recruiting
NCT00401661
Sexuality And Management of Benign Prostatic Hyperplasia With Alfuzosintreatment4completed
NCT03385161
Intraprostatic Injection of Botulinum Toxin A Versus Ethanol for Treatment of Patients With Benign Prostatic HyperplasiaNo drug interventionstreatmentNot Availablecompleted
NCT00596011
Study of Polyphenon E in Men With High-grade Prostatic Intraepithelial Neoplasiaprevention2completed
NCT01577693
Study to Compare the Bioavailability of Dutasteride Novel Formulation Form to the Soft Gel Capsule Form in Healthy Male Subjectstreatment1completed
NCT00116571
Photodynamic Therapy (PDT) for Lower Urinary Tract Symptoms (PLUS)treatment2terminated
NCT06209307
Pelvic Floor Physical Therapy to Reduce Stress Urinary Incontinence After Holmium Laser Enucleation of the ProstateNo drug interventionstreatmentNot Availableenrolling_by_invitation
NCT02244307
Observational Study in Patients Suffering From Benign Prostatic Hyperplasia Treated With Alpha-adrenergic BlockadeNo drug interventionsNot AvailableNot Availablecompleted
NCT03228485
Benign Prostatic Hyperplasia (BPH) Mobile Application Pilot StudyNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT00563485
Randomized Trial Comparing Terazosin 5 mg Daily and Doxazosin GITS 4 mg Daily for Trial Without Catheter in Acute Urinary Retention With Long Term Follow uptreatmentNot Availableterminated
NCT00169585
Levofloxacin For The Management Of Patients With Abnormal Prostate Specific Antigen (PSA)other3completed
NCT02243085
Predictors of de Novo Urge Urinary Incontinence After Photoselective Vaporization of the ProstateNo drug interventionsNot AvailableNot Availableunknown_status
NCT02033785
Functional Changes of Urogenital System After Holmium Laser ProstatectomyNo drug interventionsNot AvailableNot Availableunknown_status
NCT00486785
SAMBA: Sexuality And Management of Benign Prostatic Hyperplasia With Alfuzosintreatment4completed
NCT00822952
Prostate Mechanical Imager (PMI) Clinical Bridging StudyNo drug interventionsNot AvailableNot Availablecompleted
NCT02366975
TRT on BPH Hypoganadal MetS Patients. Florence-PROTESTtreatment4completed
NCT03554070
Thulium Fiber Laser Enucleation of the Prostate (ThuFLEP): Efficacy and SafetyNo drug interventionstreatmentNot Availableunknown_status
NCT01390870
Establishing Predictors of Enlarged Prostate Treatment Adherence: Linking Symptom Improvement to AdherenceNot AvailableNot Availablecompleted
NCT02496442
Aqueduct Irrigation System Clinical Protocol: Medical Device Investigational PlanNo drug interventionsNot AvailableNot Availableunknown_status
NCT02073799
Storage Symptom After Laser ProstatectomyNo drug interventionsNot AvailableNot Availableunknown_status
NCT02347436
Does Benign Prostatic Obstruction Cause Hypertension?No drug interventionsNot AvailableNot Availablecompleted
NCT06091618
Laser Vaporization of the Prostate: Comparing Between Ejaculatory Preserving and Non-ejaculatory Preserving TechniqueNo drug interventionstreatmentNot Availablerecruiting
NCT06001619
Prostate Medication, Metabolism and Gut Microbiotaother4recruiting
NCT04590534
Evaluation of the Effect of Garcinia in Combination With Chromium on the Clinical Outcomes of Patients With LUTS/BPHNo drug interventionstreatment2recruiting
NCT05023824
Efficacy of α-blocker or 5-ARI Withdrawal to Continued Combination Therapy on the Maintenance of LUTS in Men With BPHtreatment3unknown_status
NCT02947958
Teleconsultation in Counter-reference Between Tertiary and Primary Care for Patients With Benign Prostatic HyperplasiaNo drug interventionsotherNot Availablecompleted
NCT01332435
Dutasteride in Enlarged Prostate Economic Assessment: A Retrospective Database Pooled Analysis of Early 5-alpha Reductase Inhibitor UseNo drug interventionsNot AvailableNot Availablecompleted
NCT01767363
WEUSKOP5723: Prostate Cancer StudyNo drug interventionsNot AvailableNot Availablecompleted
NCT02757963
Benign Prostatic Hyperplasia (BPH) Screening Tool Case Finding Study in Subjects >=50 YearsNo drug interventionsscreening4completed
NCT01003886
A Post Marketing Surveillance Study Of Doxazosin Mesylate GITS Among Filipino Patients With Benign Prostatic Hyperplasia (BPH)Not AvailableNot Availablecompleted
NCT00029822
Clinical Trial in Males With BPH (Enlarged Prostate)prevention3completed
NCT06294366
Bipolar Transurethral Enucleation Versus Resection in the Treatment of Benign Prostatic Hyperplasia: a Comparative StudyNo drug interventionstreatmentNot Availablerecruiting
NCT01050465
MedlinePlus Health Prescriptions: Developing a Pragmatic Approach for Clinic UseNo drug interventionsNot AvailableNot Availablecompleted
NCT02396420
Prostate Artery Embolization as a Treatment for Benign Prostatic Hyperplasia in Men With Prostates Larger Than 90 GramsNo drug interventionstreatment2terminated
NCT00427882
Male Sexual Health Questionnaire (MSHQ) - Sexual Function Studytreatment4completed
NCT02592473
Prostate Artery Embolization (PAE) for Treatment of Benign Prostatic HyperplasiaNo drug interventionstreatmentNot Availableunknown_status
NCT01482676
The Role of microRNAs in Organ Remodeling in Lower Urinary Tract DysfunctionNo drug interventionsNot AvailableNot Availablecompleted
NCT02245529
Safety Profile of Secotex ® in Patients With Benign Prostatic HyperplasiaNot AvailableNot Availablecompleted
NCT01957189
This Will be an Open-label, Three-period, Fixed-sequence Study to Evaluate the Drug-drug Interaction, Pharmacokinetics and Safety of Dutasteride and Tamsulosin When Administered Alone and In-combination in Chinese Healthy Male Volunteers. The Study Will Last Approximately Eleven Weeks. Blood Samplestreatment1completed
NCT01294592
Comparative Efficacy of Dutasteride Plus Tamulosin With Lifestyle Advice Versus Watchful Waiting Plus Lifestyle Advice in the Management of Treatment naïve Men With Moderately Symptomatic Benign Prostatic Hyperplasia and Prostate Enlargementtreatment4completed
NCT03936244
Bipolar Plasmakinetic TURP Vs Monopolar TURP in the Treatment of Lower Urinary Tract SymptomsNo drug interventionstreatmentNot Availablecompleted
NCT02417844
Determine the Bioequivalence of Two Formulations of Tamsulosin HCl Capsules in Fed Male.treatment1completed
NCT01108367
Transient Urinary Incontinence After Holmium Laser Enucleation of the Prostate (HoLEP)No drug interventionsNot AvailableNot Availablecompleted
NCT02252367
Effect of 12 Weeks Treatment With Tadalafil vs Placebo on Lower Urinary Tract Symptomstreatment4completed
NCT02846467
Information Improvement for Surgical Patients Through Portable Video MediaNo drug interventionssupportive_careNot Availablecompleted
NCT02715401
PK and Safety of HCP1303 and Co-administration of HGP1201, HIP1402 Under Fed Condition in Healthy Male Volunteerstreatment1completed
NCT04331301
Bipolar Needlescopic Enucleation Versus Vapoenucleation of BPHNo drug interventionstreatmentNot Availablecompleted
NCT02509104
Bioavailability Study of Fixed Dose Combination (FDC) Dutasteride and Tamsulosin Hydrochloride (HCl) Relative to One Dutasteride and One Tamsulosin HCl Tablet in Healthy Male Subjectstreatment1completed
NCT02749604
Ejaculatory Sparing vs. Non-ejaculatory Sparing GreenLight Laser Photoselective Vaporization of the ProstateNo drug interventionstreatment4unknown_status
NCT00021814
Medical Therapy of Prostatic Symptomstreatment3completed
NCT02244255
FLOMAX® Versus HYTRIN® in Patients With the Signs and Symptoms of Benign Prostatic Hyperplasiatreatment4completed
NCT00090103
Benign Prostatic Hyperplasia Trial With Dutasteride And Tamsulosin Combination Treatmenttreatment3completed
NCT02245503
Observational Study of ALNA® (Tamsulosin) in Patients With Benign Prostatic Hyperplasia (BPH)Not AvailableNot Availablecompleted
NCT02245490
Study to Characterise the Effect of Tamsulosin on Lower Urinary Tract Symptoms (LUTS) and Detrusor Motor Activity in Patients Affected by Benign Prostatic Hyperplasia (BPH) and Storage Urinary Symptomstreatment4completed
NCT01673490
Safety and Efficacy of 0.5mg Dutasteride and 0.4mg Tamsulosin Combination Once Daily for Six Months for Benign Prostatic Hyperplasiatreatment4terminated
NCT01275521
A-botulinic Toxin for Symptomatic Benign Prostate HypertrophyNo drug interventionstreatment3completed
NCT05851521
To Evaluate LUTS and Complications Between Indwelling Catheter and Temporary Prostatic Stent in Patients Undergoing Minimally Invasive Procedures for the Treatment of Localized Prostate Cancer or Benign Prostatic Hyperplasia (HERMES)No drug interventionstreatmentNot Availablenot_yet_recruiting
NCT00454402
ALF-STONE: Alfuzosin in Uretheric Stonestreatment3terminated
NCT03955484
Benign Prostatic Hyperplasia and GlycosaminoglycanNo drug interventionsNot AvailableNot Availableunknown_status
NCT00368979
Dutasteride (GI198745) In Benign Prostatic Hyperplasia Subjectstreatment3completed
NCT00517179
Effect of Vardenafil on Blood Pressure in Patients With Erectile Dysfunction Who Received Concomitant Doxazosin GITStreatmentNot Availablecompleted
NCT00408954
Urodynamic Effects of UK-369,003 in Men With Lower Urinary Tract Symptomstreatment2completed
NCT02578953
Bioequivalence Study of Dutasteride Capsules in Healthy Japanese Male Subjectstreatment1completed
NCT03098147
The Influence of Benign Prostatic Hyperplasia on Bladder FunctionNo drug interventionsNot AvailableNot Availableunknown_status
NCT02033798
The Effect of Daily Tamsulosin 0.2mg Administration on Renal Function in Patients With Benign Prostatic HyperplasiatreatmentNot Availableunknown_status
NCT04561505
HoLEP vs mTURP in Management of Benign Prostatic HyperplasiaNo drug interventionstreatmentNot Availablecompleted
NCT00280605
ALF-ONE : ALFuzosin ONcE Dailytreatment4completed
NCT03179228
Prostate Artery Embolization for the Treatment of Benign Prostatic HyperplasiaNo drug interventionstreatmentNot Availablewithdrawn
NCT02712411
Pharmacokinetics and Safety of HCP1303 and Co-administration of HGP1201, HIP1402 in Healthy Male Volunteerstreatment1completed
NCT04108871
Whether Transperineal Prostate Biopsy Under Local-anaesthesia Using a Transperineal-access System is Non-inferior to Standard Transrectal Biopsy to Detect Prostate Cancer in Biopsy-naïve MenNo drug interventionsdiagnosticNot Availableunknown_status
NCT01299571
AVODART(Dutasteride) Post-marketing Surveillance(PMS)Not AvailableNot Availablecompleted
NCT01254071
A Study to Determine the Bioavailability of a Fixed Dose Combination Product of Dutasteride (0.5mg) and Tamsulosin Hydrochloride (0.2mg) Relative to Co-administration of the Individual Components in Healthy Male Subjects of North East Asian and Non-Asian Ancestry.treatment1completed
NCT01471678
Bioavailability of Two Combination Products of Dutasteride (0.5mg) and Tamsulosin Hydrochloride (0.2mg) in Asian Males.treatment1completed
NCT02184585
Comparative Bioavailability of Two Fixed Dose Combination (FDC) Formulations of Dutasteride and Tamsulosin Hydrochloride Relative to Co-administration of Dutasteride With Tamsulosin Hydrochloride in Healthy Male Subjects Under Fed and Fasted StatesNo drug interventionsother1completed
NCT00316732
Observational AVODART (Dutasteride) Study In Benign Prostatic Hyperplasia Subjects - OASISNo drug interventionsNot AvailableNot Availablecompleted
NCT06148259
SGLT Inhibitors Versus DDP4 Inhibitors and Prostate in Patient With DiabetesNo drug interventionsdiagnosticNot Availablecompleted
NCT06116370
The Clinical Efficacy of Rezūm Therapy Versus Bipolar Trans-urethral Resection of the Prostate for Treatment Benign Prostatic HyperplasiaNo drug interventionstreatmentNot Availablecompleted
NCT02943070
Rezum I Pilot Study for Benign Prostatic HyperplasiaNo drug interventionstreatmentNot Availablecompleted
NCT02245542
The Impact of Alna® Ocas® on Nocturia in Patients With Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (LUTS/BPH)No drug interventionsNot AvailableNot Availablecompleted
NCT02244242
Study to Evaluate the Symptomatic Relief Effects of FLOMAX® in Patients With Signs and Symptoms of Benign Prostatic Hyperplasiatreatment4completed
NCT00510406
A Study With Combination Treatment (Tamsulosin Hydrochloride and Solifenacin Succinate) in Male Patients With LUTS/BPHtreatment2completed
NCT00814736
A Randomized, Double-Blinded, Placebo-Controlled, Two-Way Crossover Study to Investigate the Safety and Toleration of Single Dose Sildenafil in Subjects Receiving Chronic UK-369,0031basic_science1completed
NCT06568718
Efficacy and Safety of Longidaze in the Treatment of Lower Urinary Tract Symptoms Associated With Benign Prostatic HyperplasiatreatmentNot Availablecompleted
NCT00793819
A Study of Silodosin 8 mg Daily for the Treatment of Nocturia in Men With Benign Prostatic Hyperplasiatreatment2completed
NCT03474419
Evaluation of the Satisfaction of the Patients Operated for a Mild Hyperplasie of the Prostate by Laser in Ambulatory SurgeryNo drug interventionsNot AvailableNot Availablewithdrawn
NCT06242119
Clinical Application of the J-PET Scanner PrototypeNo drug interventionsNot AvailableNot Availablerecruiting
NCT02737241
HoLEP (50W) vs. HoLEP (100W) for Treatment of BPHNo drug interventionstreatmentNot Availablecompleted
NCT06565741
EEAP Using Moses 2.0 Technology vs the Thulium Fiber Laser in Medium-Large ProstatesNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT03589196
Ejaculation Preserving Photoselective Vaporization Versus Plasma Kinetic Vaporization Versus Transurethral Resection Of The Prostate: A RCTNo drug interventionstreatmentNot Availableunknown_status
NCT00609596
A Study To Compare 3 Different Formulations Of Tamsulosin At Steady State.treatment1completed
NCT01376258
Benefits of Adherence to 5-alpha Reductase Inhibitor Treatment in Men With Enlarged Prostate: An Assessment of Medicare and Medicaid Patients Using the MarketScan DatabaseNot AvailableNot Availablecompleted
NCT05506735
The Role of the Seven Sweeps in the Prevention of the Prostate Cancer Among Those With a Positive Family HistoryNo drug interventionsNot AvailableNot Availablecompleted
NCT00497939
The Effectiveness of Saw Palmetto and Sanmiaoshan on Benign Prostatic Hyperplasia in Chinese PatientstreatmentNot Availableunknown_status
NCT05686525
Clinical Trial on the Effectiveness of TUMT Compared to PAE in Reducing Severe LUTS in Men With BPHNo drug interventionstreatmentNot Availablerecruiting
NCT00547625
Study to Determine Safety and Effectiveness of Tadalafil on Prostate Related Sex Organ/Urinary Tract Problemstreatment2completed
NCT00290030
ALFAURUS : A DB Randomized Parallel Group Study of Alfuzosin 10mg OD vs Placebo in the Management of AUR in Patients With a 1st Episode Due to BPHtreatment3completed
NCT04588857
Efficacy of a Single Dose Dexamethasone in Reducing the Postembolization Syndrome in Men Undergoing Prostatic Artery Embolization for Benign Prostatic Hyperplasiatreatment4unknown_status
NCT00457457
Study the Effects of Different Doses of UK-369,003 in Men With Lower Urinary Tract Symptoms.treatment2completed
NCT00044226
A 20-Week Study of a New Treatment for Men With Benign Prostatic Hyperplasia (BPH).No drug interventionstreatment2unknown_status
NCT01495026
A Study Assessing a Range of Formulations of the Fixed Dose Combination Product Containing Dutasteride (0.5mg) and Tamsulosin Hydrochloride (0.2mg) to Find a Formulation Which is Bioequivalent to Harnal-D Tablets (Tamsulosin Hydrochloride, 0.2mg) in Healthy Male Subjects From North East Asiatreatment1completed
NCT04398966
Prostatic Artery Embolization vs Medication for Benign Prostatic HyperplasiaNo drug interventionstreatmentNot Availableterminated
NCT02244320
Observational Study in Patients With Functional Benign Prostatic Hyperplasia Symptoms Who Switched From Phytotherapy to ALNA® (Tamsulosin)Not AvailableNot Availablecompleted
NCT03064282
Prostatic Hyperplasia Treatment and Cancer Preventiontreatment0unknown_status
NCT02417831
Determine the Bioequivalence of Two Formulations of Tamsulosin HCl Capsules in Fasted Male.treatment1completed
NCT00885027
MEN STUDY (ESTUDIO MEN) Quality of Life in Patients With BPH and Nocturia Before and After Tamsulosin Ocas® TreatmentNo drug interventionsNot AvailableNot Availablecompleted
NCT06452927
EEP in Patients With Urodynamically Proven DU/DANo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT02244229
Study to Evaluate the Therapeutic Action of Tamsulosin and Finasteride in Symptomatic Benign Prostatic Hyperplasia (BPH) Patientstreatment4completed
NCT01262989
SECOTEX® (Tamsulosin Hydrochloride) Bioequivalence Study Brazil - Fast AdminNo drug interventionsother1completed
NCT02243540
Impact of Bladder Underactivity on Treatment Outcomes of Laser ProstatectomyNo drug interventionsNot AvailableNot Availableunknown_status
NCT02248467
Study of the Effect of Testosterone Treatment on Metabolic Parameters and Urinary Symptoms in Bariatric PatientsNo drug interventionsNot AvailableNot Availablecompleted
NCT00969072
Extension Study of GI198745 to Treat Benign Prostatic Hyperplasiatreatment2completed
NCT02058368
Study to Compare the Efficacy and Safety of Combination Treatment With Dutasteride and Tamsulosin With Tamsulosin Monotherapy, in Men With Moderate to Severe Benign Prostatic Hyperplasiatreatment3completed
NCT02244268
Study to Evaluate the Effect of ALNA® (Tamsulosin) on the Primary Symptoms of Benign Prostatic HyperplasiaNot AvailableNot Availablecompleted
NCT06319469
The Additive Value of Pyridostigmine to Silodosin in Acute Urinary Retentiontreatment2completed
NCT01777269
Prospective Sexual Function Study for BPH Subjectstreatment4completed
NCT02244346
Prescription Event Monitoring in Patients With Benign Prostatic Hyperplasia (BPH)Not AvailableNot Availablecompleted
NCT01381510
Establishing the Benefits of Adherence to Enlarged Prostate Treatment: A Validation Study Linking Adherence to Outcomes Using the Market Scan DatabaseNot AvailableNot Availablecompleted
NCT02245555
Observational Study of Tamsulosin in Patients With Benign Prostatic HyperplasiaNot AvailableNot Availablecompleted
NCT01334723
Demonstrating the Clinical and Economic Benefit of 5 Alpha Reductase Inhibitor Adherence in Benign Prostatic HyperplasiaNot AvailableNot Availablecompleted